RedLock develops an infrastructure security platform designed to provide deep security visibility for dynamic environments.

RedLock develops internet security software. Varun Badhwar and Gaurav Kumar founded it on September 1, 2015, with its headquarters in Menlo Park in California.

RedLock

Senior Manager, Corporate Communications

Senior Manager, Corporate Communications - Products

Prisma SD-WAN is the leader in software-defined wide area networks developer.

Prisma SD-WAN is the software-defined wide-area network (SD-WAN) leader, revolutionizing networking by transforming legacy WAN's into a radically simplified, secure application-defined fabric, and virtualizing heterogeneous underlying transports into a unified hybrid WAN. Enabling application-specific service-level agreements (SLAs), Prisma SD-WAN (formerly CloudGenix) controls application performance on the network-based upon application performance SLAs and business priority. CloudGenix ION radically simplifies how WANs are designed and managed, enabling customers to build Networks without Networking and achieve more than 2x the performance at less than half the cost, leading to a much faster time-to-value once deployed and extends datacenter-class security to the network edge. Founded in 2013 by a team that has previously delivered industry-leading products in networking, SDN, cloud, security, and web-scale applications, CloudGenix serves world-class financial services, legal, retail, and technology organizations. The company is backed by Bain Capital Ventures, Charles River Ventures, and the Mayfield Fund and has headquarters in San Jose, California.

Prisma SD-WAN

Aporeto offers comprehensive cloud-native security for containers and microservices.

Aporeto offers comprehensive cloud-native security for containers and microservices. It secures all workloads across any infrastructure with identity-based access control for a Zero Trust posture. Aporeto was founded in 2016 and is based in San Jose, California.

Aporeto

Exceed is a Conversational Marketing and Sales Platform.

Exceed.ai platform helps marketing and sales teams to drive more pipeline from email and website visitors. Exceed AI Assistant works 24/7/365 alongside humans to ensures every lead is followed up with, nurtured, and qualified using two-way email and chat conversations. When a lead is qualified and ready to talk to a human the assistant will go ahead and book a meeting directly on your repâ€™s calendar. It also automatically updates your CRM and marketing automation platform with the latest lead status when leads are qualified, change jobs, leave the company, not the right person, or ask to be contacted at a later time. Learn how companies such as Demandbase, SugarCRM, Hearst, Monday.con are exceeding the goals using Exceed.ai at www.exceed.ai

Exceed.ai

Sr. Manager, Corporate Communications

Elastic builds software to make data usable in real time and at scale for search, logging, security, and analytics use cases.

Elastic develops the open source Elastic Stack (Elasticsearch, Kibana, Beats, and Logstash), X-Pack (which offers commercial features for the Elastic Stack), and Elastic Cloud (a family of SaaS offerings). To date, there have been more than 250 million cumulative downloads of the Elastic Stack.  Elastic is used by thousands of organizations including Cisco, eBay, Goldman Sachs, NASA, Microsoft, Mayo Clinic, The New York Times, Wikipedia, and Verizon to power mission-critical systems. Elastic is used for use cases that require search, logging, metrics, and security of data. Backed by Benchmark Capital, Index Ventures, and NEA with more than $100 million in funding, Elastic has a distributed workforce with more than 900 employees in 30 countries.

Elastic

Senior Manager, Corporate Messaging

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

Arcellx is a clinical-stage biotechnology company reimagining cell therapy by engineering innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx believes that cell therapies are one of the forward pillars of medicine and Arcellx‚Äôs mission is to advance humanity by developing cell therapies that are safer, more effective, and more broadly accessible. Arcellx‚Äôs lead product candidate, CART-ddBCMA, is being developed for the treatment of relapsed or refractory multiple myeloma (r/r MM) in an ongoing Phase 1 study. CART-ddBCMA has been granted Fast Track, Orphan Drug, and Regenerative Medicine Advanced Therapy designations by the U.S. Food and Drug Administration. Arcellx is also advancing its dosable and controllable CAR-T therapy, ARC-SparX, into the clinic through two programs: ACLX-001 in r/r MM and ACLX-002 in relapsed or refractory acute myeloid leukemia.

Location

Company Stage

Age of Data

Experience

Industry

Company

Senior Manager, Corporate Communications

RedLock

$147k - $238k

$147,000 - $237,700

Prisma SD-WAN

$147k - $238k

$147,000 - $237,700

Aporeto

$147k - $238k

$147,000 - $237,700

Exceed.ai

$116k - $227k

$115,850 - $227,350

Elastic

$128k - $203k

$128,200 - $202,900

Arcellx

$120k - $160k

$120,000 - $160,000